Zhiyi Lan

5 ta ish

McGill University Health Centre

1. Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses

   Faiz Ahmad Khan, M Salim, Philipp du Cros +9

   Sharh maqolaOAOchiq kirishTuberculosis Research and EpidemiologyEuropean Respiratory Journal20174 iqtibos

   ABIABI:AkademIndex/2017.review-article.000004

2. Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis

   Zhiyi Lan, Nafees Ahmad, Parvaneh Baghaei +35

   Sharh maqolaOAOchiq kirish20204 iqtibos

   ABIABI:AkademIndex/2026.other.006851

3. An updated systematic review and meta-analysis for treatment of multidrug-resistant tuberculosis

   Mayara Lisboa Bastos, Zhiyi Lan, Dick Menzies

   Sharh maqolaOAOchiq kirish20174 iqtibos

   ABIABI:AkademIndex/2026.other.027999

4. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

   Nafees Ahmad, Shama D. Ahuja, Onno W. Akkerman +97

   Sharh maqolaOAOchiq kirish20184 iqtibos

   ABIABI:AkademIndex/2026.other.034216

5. Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

   S.K. Abidi, Jay Achar, M.M. Assao Neino +34

   MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyEuropean Respiratory Journal20191 iqtibos

   ABIABI:AkademIndex/2019.article.000020